Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
HIV/AIDS
Researchers at Emory University, Emory Vaccine Center release new data on HIV/AIDS
April 22nd, 2009
According to recent research published in the Jaids - Journal of Acquired Immune Deficiency Syndromes, "The Step Study, a Phase IIb HIV vaccine proof of concept study, enrolled approximately 3000 persons in clade B regions. The Atlanta site sought to enroll a diverse Population." "This prospective cohort study examined key factors associated with participant enrollment. We obtained participant information (eg, sociodemographic, medical) and followed outcomes from 2005 to 2007. Of the 810 potential ''Step Study'' participants, 340 cases were analyzed. The recruitment strategy generated strong interest among minorities with 37% eligible after prescreening, yet 25%...
Source: Vaccine Weekly (2009-04-22)
|
